Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization

被引:30
作者
Alvarez, S
MacGrogan, D
Calasanz, MJ
Nimer, SD
Jhanwar, SC
机构
[1] Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, New York, NY 10021 USA
[2] Sloan Kettering Inst Canc Res, Lab Mol Aspects Hematopoiesis, New York, NY USA
[3] Univ Navarra, Dept Genet, Navarra, Spain
[4] Mem Sloan Kettering Canc Ctr, Dept Human Genet, Cytogenet Serv, New York, NY 10021 USA
关键词
D O I
10.1002/gcc.1192
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute megakaryocytic leukemia is a rare subtype of AML that is often difficult to diagnose; it is most commonly associated with Down syndrome in children. To identify chromosomal imbalances and rearrangements associated with acute megakaryocytic leukemia, we used G-banding, comparative genomic hybridization (CGH), and whole chromosome painting (WCP) on a variety of primary patients' samples and leukemia cell lines. The most common abnormality was gain of chromosome 19 or arm 19q, which was detected by CGH in four of 12 (33.3%) primary samples and nine of 11 (81.8%) cell lines. In none of the primary samples was this abnormality detected by G-banding analysis. WCP was used to define further the nature of the chromosome 19 gain in the cell lines, which was found to be due to the presence of additional 19q material on marker chromosomes or to cryptic translocations involving 19q. The most common chromosomal loss-detected only in the cell lines-was deletion of chromosomal band 13q14, which was seen in six of 11 (54.5%) cell lines. Other recurrent changes included gains of 1p, 6p, 8q, 11q, 15q, 17q, and 21q and losses of 2, 4q, 5q, 7q, 9p, and 11p. Combining conventional and molecular cytogenetic analyses defined recurrent clonal chromosomal abnormalities, which will aid in the identification of critical genes that are abnormal in acute megakaryocytic leukemia cells. (C) 2001 WIley-Liss, Inc.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 46 条
[1]  
[Anonymous], CANC CYTOGENETICS CH
[2]   M-07E HUMAN LEUKEMIC FACTOR-DEPENDENT CELL-LINE PROVIDES A RAPID AND SENSITIVE BIOASSAY FOR THE HUMAN CYTOKINES GM-CSF AND IL-3 [J].
AVANZI, GC ;
BRIZZI, MF ;
GIANNOTTI, J ;
CIARLETTA, A ;
YANG, YC ;
PEGORARO, L ;
CLARK, SC .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 145 (03) :458-464
[3]   Nineteen cases of the t(1;22)(p13;q13) acute megakaryoblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group [J].
Bernstein, J ;
Dastugue, N ;
Haas, OA ;
Harbott, J ;
Heerema, NA ;
Huret, JL ;
Landman-Parker, J ;
LeBeau, MM ;
Leonard, C ;
Mann, G ;
Pages, MP ;
Perot, C ;
Pirc-Danoewinata, H ;
Roitzheim, B ;
Rubin, CM ;
Slociak, M ;
Viguie, F .
LEUKEMIA, 2000, 14 (01) :216-218
[4]  
BITTER MA, 1985, BLOOD, V66, P1362
[5]  
Byrne JL, 1998, BRIT J HAEMATOL, V100, P256
[6]  
CARROLL A, 1991, BLOOD, V78, P748
[7]   REPRODUCIBILITY OF THE MORPHOLOGICAL DIAGNOSTIC-CRITERIA FOR ACUTE MYELOID-LEUKEMIA - THE GIMEMA GROUP EXPERIENCE [J].
CASTOLDI, GL ;
LISO, V ;
FENU, S ;
VEGNA, ML ;
MANDELLI, F .
ANNALS OF HEMATOLOGY, 1993, 66 (04) :171-174
[8]   AKT2, A PUTATIVE ONCOGENE ENCODING A MEMBER OF A SUBFAMILY OF PROTEIN-SERINE THREONINE KINASES, IS AMPLIFIED IN HUMAN OVARIAN CARCINOMAS [J].
CHENG, JQ ;
GODWIN, AK ;
BELLACOSA, A ;
TAGUCHI, T ;
FRANKE, TF ;
HAMILTON, TC ;
TSICHLIS, PN ;
TESTA, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9267-9271
[9]   Amplification of AKT2 in human pancreatic cancer cells and inhibition of ATK2 expression and tumorigenicity by antisense RNA [J].
Cheng, JQ ;
Ruggeri, B ;
Klein, WM ;
Sonoda, G ;
Altomare, DA ;
Watson, DK ;
Testa, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3636-3641
[10]   Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization [J].
Cigudosa, JC ;
Rao, PH ;
Calasanz, MJ ;
Odero, MD ;
Michaeli, J ;
Jhanwar, SC ;
Chaganti, RSK .
BLOOD, 1998, 91 (08) :3007-3010